NIRF is frequently upregulated in colorectal cancer and its oncogenicity can be suppressed by let-7a microRNA

Cancer Letters

Volumn 314, Issue 2, 2012, Pages 223-231

  Wang, Feng ^a,b   Zhang, Peng ^a   Maa, Yanlei ^a,b   Yang, Jianjun ^a   Moyer, Mary Pat ^b   Shi, Chenzhang ^a   Peng, Jiayuan ^a   Qin, Huanlong ^a  

^a SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

^b INCELL Corporation ^*  (United States)

Author keywords

CRC; Let 7a; Nirf; Oncogenicity; Overall; Survival

Indexed keywords

ANTINEOPLASTIC AGENT; MICRORNA; MICRORNA LET 7A; NP95 ICBP90 RING FINGER PROTEIN; UBIQUITIN; UNCLASSIFIED DRUG; MIRNLET7 MICRORNA, HUMAN; UBIQUITIN PROTEIN LIGASE; UHRF2 PROTEIN, HUMAN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOINFORMATICS; CANCER CELL; CANCER INHIBITION; CANCER SURVIVAL; CARCINOGENICITY; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL MIGRATION; CELL PROLIFERATION; COLON CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; G1 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN RNA BINDING; PROTEIN TARGETING; REGULATORY MECHANISM; TISSUE SECTION; UPREGULATION; 3' UNTRANSLATED REGION; AGED; ANIMAL; BAGG ALBINO MOUSE; COLORECTAL TUMOR; GENETICS; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

MUS MUSCULUS;

3' UNTRANSLATED REGIONS; ADULT; AGED; ANIMALS; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICRORNAS; MIDDLE AGED; UBIQUITIN-PROTEIN LIGASES;

EID: 84862833636     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2011.09.033     Document Type: Article

References (27)

1. A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, T. Murray, M.J. Thun, Cancer statistics, 2008, CA Cancer J. Clin. 58 (2008) 71-96.
2. T. Mori, Y. Li, H. Hata, K. Ono, H. Kochi, NIRF, a novel RING finger protein, is involved in cell-cycle regulation, Biochem. Biophys. Res. Commun. 296 (2002) 530-536.
3. C. Bronner, M. Achour, Y. Arima, T. Chataigneau, H. Saya, V.B. Schini-Kerth, The UHRF family: oncogenes that are drugable targets for cancer therapy in the near future?, Pharmacol Ther. 115 (2007) 419- 434.
4. Y. Li, T. Mori, H. Hata, Y. Homma, H. Kochi, NIRF induces G1 arrest and associates with Cdk2, Biochem. Biophys. Res. Commun. 319 (2004) 464-468.
5. R. Hass, I. Prudovsky, M. Kruhoffer, Differential effects of phorbol ester on signaling and gene expression in human leukemia cells, Leukemia Res. 21 (1997) 589-594.
6. X. He, C. Duan, J. Chen, X. Ou-Yang, Z. Zhang, C. Li, H. Peng, Let-7a elevates p21WAF1 levels by targeting of NIRF and suppresses the growth of A549 lung cancer cells, FEBS Lett. 583 (2009) 3501-3507.
7. E.C. Lai, Micro RNAs are complementary to 30 UTR sequence motifs that mediate negative post-transcriptional regulation, Nat. Genet. 30 (2002) 363-364.
8. K. Schee, O. Fodstad, K. Flatmark, MicroRNAs as biomarkers in colorectal cancer, Am. J. Pathol. 177 (2010) 1592-1599.
9. H. Schwarzenbach, D.S. Hoon, K. Pantel, Cell-free nucleic acids as biomarkers in cancer patients, Nat. Rev. Cancer 11 (2011) 426-437.
10. M. Inui, G. Martello, S. Piccolo, MicroRNA control of signal transduction, Nat. Rev. Mol. Cell Biol. 11 (2010) 252-263.
11. A. Lugli, G. Iezzi, I. Hostettler, M.G. Muraro, V. Mele, L. Tornillo, V. Carafa, G. Spagnoli, L. Terracciano, I. Zlobec, Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer, Br. J. Cancer 103 (2010) 382-390.
12. M.P. Moyer, L.A. Manzano, R.L. Merriman, J.S. Stauffer, L.R. Tanzer, NCM460, a normal human colon mucosal epithelial cell line, In Vitro Cell Dev. Biol. Anim. 32 (1996) 315-317.
13. D. Zhao, A.C. Keates, S. Kuhnt-Moore, M.P. Moyer, C.P. Kelly, C. Pothoulakis, Signal transduction pathways mediating neurotensinstimulated interleukin-8 expression in human colonocytes, J. Biol. Chem. 276 (2001) 44464-44471.
14. J.G. Doench, C.P. Petersen, P.A. Sharp, siRNAs can function as miRNAs, Genes Dev. 17 (2003) 438-442.
15. K.J. Livak, T.D. Schmittgen, Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method, Methods 25 (2001) 402-408.
16. A. Rottach, C. Frauer, G. Pichler, I.M. Bonapace, F. Spada, H. Leonhardt, The multi-domain protein Np95 connects DNA methylation and histone modification, Nucl. Acids Res. 38 (2010) 1796-1804.
17. C. Qian, S. Li, J. Jakoncic, L. Zeng, M.J. Walsh, M.M. Zhou, Structure and hemimethylated CpG binding of the SRA domain from human UHRF1, J. Biol. Chem. 283 (2008) 34490-34494.
18. M. Achour, X. Jacq, P. Ronde, M. Alhosin, C. Charlot, T. Chataigneau, M. Jeanblanc, M. Macaluso, A. Giordano, A.D. Hughes, V.B. Schini-Kerth, C. Bronner, The interaction of the SRA domain of ICBP90 with a novel domain of DNMT1 is involved in the regulation of VEGF gene expression, Oncogene 27 (2008) 2187-2197.
19. T. Mori, Y. Li, H. Hata, H. Kochi, NIRF is a ubiquitin ligase that is capable of ubiquitinating PCNP, a PEST-containing nuclear protein, FEBS Lett. 557 (2004) 209-214.
20. B. Bierie, H.L. Moses, TGF-beta and cancer, Cytokine Growth Factor Rev. 17 (2006) 29-40.
21. K. Ruan, X. Fang, G. Ouyang, MicroRNAs: novel regulators in the hallmarks of human cancer, Cancer Lett. 285 (2009) 116-126.
22. O. Slaby, M. Svoboda, J. Michalek, R. Vyzula, MicroRNAs in colorectal cancer: translation of molecular biology into clinical application, Mol. Cancer 8 (2009) 102.
23. Y. Dong, W.K. Wu, C.W. Wu, J.J. Sung, J. Yu, S.S. Ng, MicroRNA dysregulation in colorectal cancer: a clinical perspective, Br. J. Cancer 104 (2011) 893-898.
24. C. Mayr, M.T. Hemann, D.P. Bartel, Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation, Science 315 (2007) 1576-1579.
25. F. Meng, R. Henson, H. Wehbe-Janek, H. Smith, Y. Ueno, T. Patel, The MicroRNA let-7a modulates interleukin-6-dependent STAT-3 survival signaling in malignant human cholangiocytes, J. Biol. Chem. 282 (2007) 8256-8264.
26. C.D. Johnson, A. Esquela-Kerscher, G. Stefani, M. Byrom, K. Kelnar, D. Ovcharenko, M. Wilson, X. Wang, J. Shelton, J. Shingara, L. Chin, D. Brown, F.J. Slack, The let-7 microRNA represses cell proliferation pathways in human cells, Cancer Res. 67 (2007) 7713-7722.
27. S.M. Johnson, H. Grosshans, J. Shingara, M. Byrom, R. Jarvis, A. Cheng, E. Labourier, K.L. Reinert, D. Brown, F.J. Slack, RAS is regulated by the let-7 microRNA family, Cell 120 (2005) 635-647.